Scottish company Airglove Medical are pleased to announce the launch of Airglove v2, a revolutionary air warming system, developed to enhance vein physiology prior to venepuncture and improve access in patients with difficult intravenous access. It is a proven patient solution to make cannulation easier, faster and more comfortable for the benefit of patients and staff.
The award-winning system was officially launched at the recent UKONS conference in Birmingham following extensive and highly successful oncology trials in more than 150 UK hospitals since 2018, including Royal Marsden Cancer Centre, Guy’s and St Thomas’ Hospital and St Barts Hospital. The initial patient service evaluation achieved 87.5% first time cannulation in NHS Maidstone & Tunbridge Wells Oncology Department, with Oncology being regarded as having some of the most difficult to access veins.
With over 32,000,000 cannulations per year in the UK alone and a reported 30% failure rate of accessing the vein first time, this worldwide patented air warming system is set to transform the market, it gently heats the patients arm up as it forces warm air through a double walled polyethylene (LDPE) glove to warm the underlying structures and blood which dilates the veins.
Jason Ram, Chief Executive Officer at Airglove Medical said, “Our mission at Airglove is to positively impact the lives of patients, in a small but mighty way. Protecting precious veins is vital through a treatment journey, which has a physical and mental impact. We want to balance the scales of the unintended consequences of IV access through vein preparation and reducing anxiety.”
Airglove aims to improve workflow, reduce procedure delays, with positive feedback received from both staff and patients. It is an example of how simple innovation can solve complex problems bridging the gap between technology and care.
For further information and to request a trial please email info@airglovemedical.com
Airglove Medical – Award-winning UK innovators
